Literature DB >> 1727670

Protein kinase C activity in human colonic adenoma and colorectal carcinoma.

M Kusunoki1, Y Sakanoue, T Hatada, H Yanagi, T Yamamura, J Utsunomiya.   

Abstract

To additionally understand the molecular mechanisms and biologic indicators of colonic tumorigenesis through the adenoma-carcinoma sequence, protein kinase C (PKC) activity was examined in the cytosol and particulate fraction of specimen homogenates from 18 human colonic carcinomas and seven coexisting colonic adenomas and was compared with the adjacent normal mucosal tissues. This study showed that PKC activity could be detected precisely using mini DEAE-Sephacel column purification and histone III-S as a substrate. The PKC activity in both colonic adenoma and carcinoma progressively was reduced in the particulate fraction compared with that of the adjacent normal mucosa from each patient (74.9 +/- 11.3 and 42.4 +/- 9.37 versus 112 +/- 16.8 pmol/min/mg, P less than 0.001), although PKC activity in the cytosolic fraction was not significantly different (62.6 +/- 17.7 and 63.1 +/- 8.08 versus 56.4 +/- 7.32 pmol/min/mg) with respect to protein concentration. Both colonic adenomas and carcinomas showed a significant progressive decrease in total particulate PKC activity compared with the adjacent normal mucosa of each patient (13.5 +/- 2.18 and 7.64 +/- 1.35 versus 19.8 +/- 2.74 pmol/min/g tissue, P less than 0.001) and no difference in total cytosolic PKC activity (15.2 +/- 3.80 and 16.5 +/- 2.02 versus 14.6 +/- 1.81 pmol/min/g tissue). Among PKC activities in carcinomas, there was no difference related to histologic type, Dukes' staging, or carcinoembryonic antigen values. Among PKC activities in colonic adenomas, a significant decrease in particulate PKC correlated with size. The specific PKC activity in the particulate fraction decreased with advancing adenoma size (P less than 0.05). This study showed that colonic carcinogenesis might be associated with alterations in cellular levels of PKC activity and that the decrease in particulate PKC activity in the adenoma had a possible correlation with adenoma size.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1727670     DOI: 10.1002/1097-0142(19920101)69:1<24::aid-cncr2820690107>3.0.co;2-1

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

1.  Mechanistic insight into the ability of American ginseng to suppress colon cancer associated with colitis.

Authors:  Xiangli Cui; Yu Jin; Deepak Poudyal; Alexander A Chumanevich; Tia Davis; Anthony Windust; Anne Hofseth; Wensong Wu; Joshua Habiger; Edsel Pena; Patricia Wood; Mitzi Nagarkatti; Prakash S Nagarkatti; Lorne Hofseth
Journal:  Carcinogenesis       Date:  2010-08-20       Impact factor: 4.944

2.  Protein kinase C alpha-, beta- and gamma-subspecies in basal granulated cells of rat duodenal mucosa.

Authors:  N Kawakita; Y Nagahata; Y Saitoh; C Ide
Journal:  Anat Embryol (Berl)       Date:  1995-04

3.  Protein kinase C (PKC) activity and PKC messenger RNAs in human pituitary adenomas.

Authors:  L Jin; T Maeda; W F Chandler; R V Lloyd
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

4.  Ellagic acid checks lymphoma promotion via regulation of PKC signaling pathway.

Authors:  Sudha Mishra; Manjula Vinayak
Journal:  Mol Biol Rep       Date:  2012-10-31       Impact factor: 2.316

5.  Protein kinase C activity as a potential marker for colorectal neoplasia.

Authors:  T J McGarrity; L P Peiffer
Journal:  Dig Dis Sci       Date:  1994-03       Impact factor: 3.199

6.  Growth inhibition, enhancement of intercellular adhesion, and increased expression of carcinoembryonic antigen by overexpression of phosphoinositides-specific phospholipase C beta 1 in LS174T human colon adenocarcinoma cell line.

Authors:  K Nomoto; N Tomita; M Miyake; D B Xhu; P R LoGerfo; I B Weinstein
Journal:  Jpn J Cancer Res       Date:  1998-12

7.  Increased constitutive activity of mitogen-activated protein kinase and renaturable 85 kDa kinase in human-colorectal cancer.

Authors:  J Ostrowski; L Trzeciak; J Kołodziejski; K Bomsztyk
Journal:  Br J Cancer       Date:  1998-11       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.